What is the current Price Target for the Leap Therapeutics, Inc. stock?

The average Leap Therapeutics, Inc. target price is $6.75. This is 2,210.06% higher than the current stock price. The highest price target is 2,637.85%, the lowest is 1,782.27%. 2 Analysts have issued a price target Leap Therapeutics, Inc. 2026 .

How high will the Leap Therapeutics, Inc. stock rise?

No reliable answer can be given as to how high the Leap Therapeutics, Inc. stock will rise. The performance of stocks, including the Leap Therapeutics, Inc. stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Leap Therapeutics, Inc. stock today?

The performance of Leap Therapeutics, Inc. stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Leap Therapeutics, Inc. stock fall?

The decline in Leap Therapeutics, Inc. stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Leap Therapeutics, Inc. Forecast, price target & analysts

$0.29

10.02% yesterday

Nasdaq, Apr 07, 10:13 pm CET

ISIN

US52187K1016

Symbol

LPTX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Biotechnology

Overview Dividends Analysts Charts News Strategies

Leap Therapeutics, Inc. Target price 2025 - Analyst rating & recommendation

Leap Therapeutics, Inc. Classifications & Recommendation:

Buy

50%

Hold

50%

Leap Therapeutics, Inc. Price Target

Target Price	$6.75
Price	$0.29
Potential	2,210.06% register free of charge
Number of Estimates	2

	2 Analysts have issued a price target Leap Therapeutics, Inc. 2026 . The average Leap Therapeutics, Inc. target price is $6.75. This is 2,210.06% register free of charge higher than the current stock price. The highest price target is $8.00 2,637.85% register free of charge , the lowest is $5.50 1,782.27% register free of charge .
	A rating was issued by 2 analysts: 1 Analysts recommend Leap Therapeutics, Inc. to buy, 1 to hold and 0 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Leap Therapeutics, Inc. stock has an average upside potential 2026 of 2,210.06% register free of charge . Most analysts recommend the Leap Therapeutics, Inc. stock at Buy or hold.

Current Leap Therapeutics, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
HC Wainwright & Co.	Locked ➜ Locked	Locked	Mar 27 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 29 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Jan 16 2025
HC Wainwright & Co.	Locked ➜ Locked	Locked	Nov 15 2024

Analyst Rating	Date
Locked HC Wainwright & Co.: Locked ➜ Locked	Mar 27 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 29 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Jan 16 2025
Locked HC Wainwright & Co.: Locked ➜ Locked	Nov 15 2024

Discover more stocks with a high price target

MongoDB 96.77%

Coinbase Global, Inc. 95.22%

BioNTech SE - ADR 59.48%

Snowflake 58.39%

Alibaba Group Holding Ltd 58.36%

PayPal 58.24%

NIO ADR 57.59%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now

The Apple stock at a glance with charts, current key metrics, news and stock analyses.

The Best Dividend Stocks in the Dividend Top Scorer list.

Stock Analyses of the Best Stocks Worldwide.

Start building wealth today